HomeTrading IdeasGold Prices Slip Amid...

Gold Prices Slip Amid Trump’s Tariff Delay and Fed Rate Cut Speculations

Gold Pressured by Trade Tariffs

On Monday, U.S. President Donald Trump posted letters on Truth Social addressed to the leaders of 14 countries. He threatened to impose tariffs ranging from 25% to 40% on imports unless countries address trade imbalances. The letters targeted China, Germany, Japan, Mexico, and India, escalating global trade tensions just weeks ahead of the Republican National Convention. Preliminary estimates suggest the tariffs could affect over $1.2 trillion in goods, raising concerns among multinational exporters and supply chain operators.

However, market fears eased somewhat after Trump signed an executive order late on Monday delaying the implementation of tariffs from 9 July to 1 August, granting over three additional weeks for negotiations. The delay also applies to the sweeping ’reciprocal tariffs’ plan targeting most U.S. trade partners. Trump stated this would ’allow allies to come to the table’ while maintaining pressure for new bilateral deals.

Adding further pressure on , a robust U.S. jobs report released on Friday showed nonfarm payrolls rose by 147,000 in June, significantly above the 110,000 expected. Meanwhile, the unemployment rate fell towards 4.1%. The data have alleviated concerns of a slowing U.S. economy, prompting traders to scale back expectations of a Federal Reserve (Fed) in July. The CME FedWatch Tool shows the probability of a rate cut this month has fallen below 6%, down from 42% just a week ago. Expectations of a less dovish monetary policy are pushing Treasury yields higher and weighing on demand for non-yielding assets such as gold (XAU).

Gold prices fell towards $3,330 during the Asian and early European trading sessions, sliding from the recent high of $3,410. The decline happened amid optimism that potential trade deals before August could reduce geopolitical risks and the demand for the metal. Analysts at Citi noted that if a last-minute trade deal is reached with China, gold could test support near $3,250 in the coming weeks, while continued uncertainty may trigger a quick rebound towards $3,400.

Euro Declines as Chances of Fed Rate Cuts Decrease

The euro () fell by 0.6% on Monday due to worries about trade tensions and reduced expectations of near-term interest rate cuts by the Federal Reserve (Fed).

On Monday, U.S. President Donald Trump announced new tariff rates targeting 14 countries that have yet to secure trade deals with Washington. The announcement triggered caution in currency markets, as investors considered the potential impact on global trade flows and the broader economic outlook if the measures take effect next month.

Major exporters such as Japan and South Korea are among the countries on the list. Both countries will face 25% levies on a range of goods if new trade agreements aren’t reached. Trump also threatened an additional 10% tariff on nations aligning with what he described as the ’anti-American policies of BRICS’, as the bloc gathered for a summit in Brazil this week. The president’s remarks reflect Washington’s increasingly aggressive stance towards trade partners as it seeks to reduce budget deficits ahead of the upcoming election cycle.

EUR/USD started to rise during today’s Asian and early European sessions. Today’s economic calendar is relatively uneventful, so volatility is likely to be low. However, investors should monitor potential shifts in U.S. trade policy closely. These developments could significantly impact the market. Key levels to watch are support at 1.11700 and resistance at 1.17500.

GBP Weakens Due to the U.K.’s Fiscal Worries

The British pound () decreased by 0.33% on Monday as investors awaited clearer signals on the fiscal path as the U.K. budget planning process advanced towards the autumn statement.

Labour’s recent retreat on proposed welfare reforms, aimed at avoiding internal party rebellion, further compounded fiscal worries. Chancellor Rachel Reeves acknowledged there were ’costs to those concessions’. She highlighted the strain on public finances as the government maintains support measures while delaying tougher structural changes.

On the monetary policy front, markets continue to price in a 25-basis-point rate cut by the Bank of England (BoE) in September, with inflation showing signs of easing but remaining above target. Policymakers face a delicate balancing act as softening economic data collides with concerns about a potential fiscal squeeze later this year. The prospect of tax rises could further dampen consumer spending, adding complexity to the BoE’s rate trajectory in the coming months.

Adding to the pound’s weakness, renewed global trade tensions have weighed on broader market sentiment after U.S. President Donald Trump said that reciprocal tariffs will take effect on 11 August for countries without trade deals. Meanwhile, Trump warned of an additional 10% tariff on countries supporting the ’anti-American policies of BRICS’. These developments have heightened risk aversion in global markets, weighing on sterling as investors seek safer assets amid uncertainty.

GBP/USD rebounded towards 1.36400 during the Asian and early European sessions as concerns deepened over the U.K.’s fiscal outlook. Reeves signalled that tax rises could be on the table in the autumn budget to address a widening public finance gap, telling The Guardian she ’wouldn’t rule them out’ amid mounting pressure to stabilise debt levels.

Most Popular

More from Author

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both...

Read Now

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to sell--but alas, it’s too late. Illiquid, Overvalued describes a great many assets that are on the books as "rock-solid investments." Illiquidity...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the American Public Health Association...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million as per data from Benzinga Pro.What HappenedZyVersa Therapeutics provided regulatory and product support for FDA-authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both China and the EU avoid tariff letters Equities are wobbly, while gold confirms lingering demand Aussie gains as RBA surprises by keeping rates unchanged Liberation Date: Version 2The approval of the US Budget Bill has allowed US President Trump...

Wall Street Is On Fire—So Why Is This Wall Of Cash Moving Abroad? – iShares Core MSCI Emerging Markets ETF (ARCA:IEMG)

U.S. stocks may be breaking records, but a flood of investor cash is moving elsewhere—toward emerging markets, where valuations are cheaper, currencies are strengthening and years of underperformance may finally be reversing.The iShares Core MSCI Emerging Markets ETF IEMG has attracted $7.4 billion in inflows so far...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after the biotech firm announced a merger agreement with Concentra Biosciences LLC.Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share, along with a non-transferable contingent value right.The CVR entitles shareholders...

Artelo Biosciences Analyst See It As An Emerging Biotech – Artelo Biosciences (NASDAQ:ARTL)

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday.The analyst upgraded from Hold to Buy and introduced a price forecast of $20.Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced peripheral neuropathy (CIN) with the lead...

Oil Prices Rebound Despite OPEC+ Output Hike as Markets Rethink Supply Risk

surged yesterday after gapping down over the weekend. The gap down came about as the + group, which includes OPEC and its allies, agreed to increase oil production by 548,000 barrels per day in August. This is a bigger rise compared to the 411,000 barrels per day...

Asian Stocks Climb as Trump Signals Openness to Trade Talks Before Tariff Deadline

Asian stock markets remained steady despite the latest update on US President Donald Trump’s tariff plans. On Tuesday, the stayed strong, and dropped. In the US, stock prices fell after Trump sent letters to 14 countries, including Japan and South Korea, announcing much higher tariffs on...

Why Is Cogent Biosciences Stock Soaring On Tuesday? – Cogent Biosciences (NASDAQ:COGT)

On Monday, Cogent Biosciences, Inc. COGT said bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis.The company said that its experimental drug reduced the symptoms of a chronic immune disorder called non-advanced systemic mastocytosis.The latest study demonstrated meaningful and highly statistically significant improvements across the...

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is the possibility that the simmering trade war may heat up after President Trump on Monday announced new tariffs set to begin on August...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).The submission is based on clinical data from the STEP UP and STEP...